[16] Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis[J]. J Thromb Haemost, 2009,7(10):1737-1740. DOI: 10.1111/j.1538-7836.2009.03555.x.
[17] Clinical and Laboratory Standards Institute. Laboratory Testing for the Lupus Anticoagulant H60-A. Approved Guideline, 2014.
[18] Danowski A, Rego J, Kakehasi AM, et al. Guidelines for the treatment of antiphospholipid syndrome[J]. Rev Bras Reumatol, 2013,53(2):184-192.
[19] Mahmoodi BK, Brouwer JL, Ten KMK, et al. A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin[J]. J Thromb Haemost, 2010,8(6):1193-1200. DOI: 10.1111/j.1538-7836.2010.03840.x.
[20] Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia[J]. Br J Haematol, 2010,149(2):209-220. DOI: 10.1111/j.1365-2141.2009.08022.x.
[21] Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2016,37(3):267-315. DOI: 10.1093/eurheartj/ehv320.
[22] Middeldorp S. How I treat pregnancy-related venous thromboembolism[J]. Blood, 2011,118(20):5394-5400. DOI: 10.1182/blood-2011-04-306589.
[23] Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012,141(2 Suppl):e691S-736S. DOI: 10.1378/chest.11-2300.